Company
Anthera Pharmaceuticals
- Business model
- B2B
Record updated 28 September 2026
About
Anthera is developing and commercializing novel therapeutics to treat serious human illnesses associated with inflammation. It went public in 2010.
Company
Record updated 28 September 2026
Anthera is developing and commercializing novel therapeutics to treat serious human illnesses associated with inflammation. It went public in 2010.
A first look at Anthera Pharmaceuticals’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.